✦ LIBER ✦

Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: Correlations with markers of inflammation and joint destruction

✍ Scribed by Patricia Jouvenne; Edouard Vannier; Charles A. Dinarello; Pierre Miossec

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 711 KB
Volume: 41
Category: Article
ISSN: 0004-3591
DOI: 10.1002/1529-0131(199806)41:6<1083::aid-art15>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble interleukin-2 receptor: Elevated

Soluble interleukin-2 receptor: Elevated levels in serum and synovial fluid of patients with rheumatoid arthritis

✍ A. B. Carpenter; C. H. Eisenbeis; Jr.; S. Carrabis; M. C. Brown; S. H. Ip 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB

Soluble interleukin-2 receptor (sll-2R) levels were quantitated in the seum and synovial fluid (SF) of patients with rheumatoid arthritis (RA) and degenerative joint disease (DJD). A sandwich immunoassay, employing two monoclonal antiodies against distinct epitopes on the lL-2R, was utilized for mea

Higher frequency of allele 2 of the inte

Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis

✍ Jiří Vencovský; Kateřina Jarošová; šárka Růžičková; Dana Němcová; Jaroslava Nied 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

Intraarticular soluble interleukin-17 re

Intraarticular soluble interleukin-17 receptor levels are increased in patients with rheumatoid arthritis and correlate with local mediators of inflammation: Comment on the article by Pickens et al

✍ Frederique M. Moret; Valerie Badot; Bernard R. Lauwerys; Joel A. G. van Roon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Combination benefit of treatment with th

Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis

✍ Alison M. Bendele; Elizabeth S. Chlipala; Jon Scherrer; Janet Frazier; Gina Senn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

Objective. To determine the potential for additive or synergistic effects of combination therapy with the recombinant anticytokine agents interleukin-1 receptor antagonist (IL-1Ra) and PEGylated soluble tumor necrosis factor receptor type I (PEG sTNFRI) in established type II collagen-induced arthri

Reduction of joint inflammation and bone

Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein

✍ Katherine A. Bush; Katherine M. Farmer; Judith S. Walker; Bruce W. Kirkham 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Objective To investigate the role of interleukin‐17 (IL‐17) in inflammatory arthritis by blockade with an IL‐17 receptor/human IgG1 Fc fusion protein (muIL‐17R:Fc) in adjuvant‐induced arthritis (AIA) in the rat. ## Methods AIA was induced in 39 DA rats with the use of Freund's com

Efficacy of sustained blood levels of in

Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: Comparison of efficacy in animal models with human clinical data

✍ Alison Bendele; Tracy McAbee; Gina Sennello; Jan Frazier; Elizabeth Chlipala; Do 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB